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include metabolic events such as stimulation of glucose
Vanadium compounds mimic insulin actions in dif- transport, glucose metabolism, lipid synthesis, and
ferent cell types. The present study concerns the insu- stimulation of glucogen synthase as well as mitogenic
lin-like effects of three vanadium(V) derivatives and activities like cell replication andDNA and protein syn-
one vanadium(IV) complex on osteoblast-like (UMR106 thesis (2–7). In bone cells in particular, insulin has
and MC3T3E1) cells in culture. The vanadium oxalate important physiological actions. It stimulates cell pro-
and vanadium citrate complexes hydrolyzed com- liferation and increases DNA and collagen synthesis
pletely under the culture conditions, whereas more (8–10). In osteoblastic lines, insulin also has metabolic
than 40% of the vanadium tartrate and nitrilotriace- effects: it regulates alkaline phosphatase activity and
tate complexes remained. Vanadate, as well as vana- stimulates the Na//K/ pump and glucose transport
dium oxalate, citrate, and tartrate complexes en- (11–16). Likewise, vanadate has been shown to mimic
hanced cell proliferation (as measured by the crystal several of the effects of insulin on osteoblast-like cells
violet assay), glucose consumption, and protein con- (4–6, 17).
tent inUMR106 andMC3T3E1 osteoblast-like cells. The
Vanadium is an essential nutritional trace elementvanadium nitrilotriacetate complex (the only peroxo
in animals, but its function is not known. Vanadiumcomplex tested) stimulated cell proliferation in
deprivation induces skeletal deformation in the fore-UMR106 but not in MC3T3E1 cells. This derivative
legs of goats (18). On the other hand, vanadium hasstrongly transformed the morphology of the MC3T3E1
been shown to induce toxic effects in several tissuescells. All vanadium(V) compounds inhibited cell differ-
at pharmacological doses. The most severe alterationsentiation (alkaline phosphatase activity) in UMR106
were observed in rat kidney in a dose-dependent andcells. Our data are consistent with the interpretation
cumulative manner (19, 20). Subcutaneous and oralthat vanadium oxalate and citrate complexes hy-
administration of radioactive vanadium show that thedrolyze to vanadate. Vanadiumnitrilotriacetatewould
appear to be toxic for normal MC3T3E1 osteoblasts. soft tissues and blood contain the maximal concentra-
In contrast, the vanadium tartrate complex induced a tion 2 h postadministration, whereas in bone the maxi-
proliferative effect; however, it did not alter cell differ- mal level was found 1 day posttreatment (21).
entiation. q 1997 Academic Press We have recently shown a direct effect of vanadium
Key Words: vanadate; aqueous vanadium chemistry; derivatives on osteoblast-like UMR106 cells (17). Vana-
stability; spectroscopy; proliferation; differentiation; date increased the cell growth in a biphasic manner,
glucose consumption; protein content; alkaline phos- with an apparent cytotoxic effect at high doses. Alka-
phatase; osteoblast-like cells. line phosphatase activity, a marker of osteoblast differ-
entiation, was inhibited at the mitogenic doses of vana-
date. On the other hand, VOSO4 and pervanadate were
also mitogenic for these cells, whereas they did notVanadate mimics various insulin actions on different
affect cell differentiation.cell types and also in cell-free systems (1). These effects
The complex aqueous chemistry of vanadium com-
pounds under conditions of physiological pH has been1 The first two authors were principal investigators.
reported in studies (22, 23) in which the vanadium com-2 To whom correspondence should be addressed. Fax: 54-21-259485
or 53-0189. E-mail: cortizo@nahuel.biol.unlp.edu.ar. pounds being examined did not remain intact during
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for use of these methods have been described elsewhere (see, forthe biological study (reviewed in 24). In the current
example, Refs. 37–39).work the biological response of different vanadium
Vanadium compounds and solution preparation. All chemicalscompounds, with varying stabilities under the physio-
obtained from Aldrich were reagent grade and used without furtherlogical study conditions, has been examined. Although purification. The vanadium compounds were prepared as crystalline
limited information is available on the nature of the solids as described previously: Na4[(VO)2(C4H2O6)]r11H2O (40),
vanadium compounds entering the cells (25–28), these K2[VO(O2)(C6H6NO6)]r2H2O (41), K[VO2(C6H6O7)]rH2O (42), and
(NH4)3[VO2(C2O4)2]r2H2O (43). Stock solutions (50.0 mM) of Vcitr,studies begin to provide information on the effects of
Voxal, V-NTA, and vanadate were prepared by dissolving the crystal-modification of the vanadium atom by organic ligands
line material in distilled water and stored at 07C. The solutions were(29–33). Such information is essential in order to iden- found to be stable for days at various concentrations (ranging from
tify whether the suggested mechanism of action of van- submillimolar to 50 mM). However, when these compounds were
added to the DMEM media in the absence of cells (cell-free system)adate or VOSO4 can indeed be attributed to an effect
and the temperature was increased to 377C, their stability varied ason protein-tyrosine-phosphatases or protein-tyrosine
described under Results.kinases (34–36).
Cell culture. Rat osteosarcoma cell line UMR106 was grown inThe present study concerns the insulin-mimetic ef-
DMEM supplemented with 10% FBS and antibiotics (100 U/ml peni-fects of vanadium derivatives on osteoblast-like cells cillin–100 mg/ml streptomycin) in a humidified atmosphere of 95%
in culture. Specifically, we demonstrate that such an air/5% CO2. Cells were grown to near confluence (70–80%) when
effect is not limited to one type of osteoblast-like cells they were subcultured using 0.1% trypsin–1 mM EDTA in Ca2/- and
Mg2/-free phosphate-buffered saline (PBS). For experiments, about(UMR106) but is also observed with a second type of
2.5 1 104 cells/well were plated into 24-well plates. MC3T3E1 cellsosteoblast-like cells (MC3T3E1). Furthermore, we de-
were grown in DMEM–10% FBS–antibiotics–5% CO2. Cells weretermine the effects of a series of vanadium compounds, subcultured using trypsin–EDTA, plated into 24-well plates, and
thus providing an insight on possible mechanisms of grown in DMEM–10% FBS as previously described (44). In experi-
ments where the MC3T3E1 cell line became confluent or culturedaction in cultured cells, in the context of their complex
for a longer period (data not shown), these cells did not respond toaqueous chemistry. Thus, the aim of this study was to
PDGF, vanadate, or to any other vanadium compounds. Thus, it wasinvestigate the species of vanadium involved in specific
essential to plate the cells at low density and to culture them for
insulin-like effects on osteoblast-like cells in culture. less than 3 days at subconfluence in order to observe the responses
of PDGF and vanadate reported previously by Davidai et al. (7).
After the culture reached 70% confluence, the cells were washed withEXPERIMENTAL PROCEDURES
DMEM without serum and incubated in 0.5 ml DMEM plus different
Materials. Vanadate, p-nitrophenylphosphate, and ethylenedi- vanadium compounds for 24 h. We chose these two cell lines since
aminetetraacetic acid (EDTA) were obtained from Sigma. Tissue cul- it was previously reported that they do respond to insulin and vana-
ture material was provided by Corning or Falcon, Dulbecco’s modified dium compounds (7–17).
Eagle’s medium (DMEM)3 and trypsin were supplied by Gibco, and
Cell proliferation assay. A mitogenic bioassay was carried out asfetal bovine serum (FBS) was supplied by Gen, Argentina.
described by Okajima et al. (45) with some modifications. Briefly,
Spectroscopy. A combination of 51V NMR, uv–vis, and EPR spec- cells in 24-well plates were washed with PBS and fixed with 5%
troscopy was used to monitor each of the vanadium compounds in glutaraldehyde/PBS at room temperature for 10 min. Then they were
the cell media and in stock solutions. Specifically, 51V NMR spectros- stained with 0.5% crystal violet/25% methanol for 10 min. After that,
copy at 79 MHz was used to measure the stability of vanadium(V) the dye solution was discarded and the plate was washed with water
compounds in solution. If the vanadium(V) compound underwent and dried. The dye taken up by the cells was extracted using 0.5 ml/
redox chemistry, these measurements were confirmed by uv–vis well 0.1 M glycine/HCl buffer, pH 3.0/30% methanol and transferred
spectroscopy (on a Perkin–Elmer lambda 4B), which gives different to test tubes. Absorbance was read at 540 nm after a convenient
absorption spectra for various vanadium compounds. For example, sample dilution. We have previously shown that under these condi-
uv–vis spectra of pure intactV-NTA and Vtar were used to obtain the tions, the colorimetric bioassay strongly correlates with cell prolifera-
extinction coefficients and/or absorbances of the original vanadium tion (17).
compounds. These coefficients were then used to monitor the disap-
Alkaline phosphatase activity. Cells were incubated at 377C/24 hpearance and/or appearance of absorbances at various wavelengths.
in a serum-free medium containing different agents. The cell layerSince the DMEMmedium is colored and absorbs in the uv and visible
was then washed with PBS and solubilized in 0.5 ml of 0.1% Tritonrange, samples were examined in the presence and the absence of
X-100. Aliquots of the total cell extract (10%) were used for proteinvanadium compounds, and the absorbance of the medium was sub-
determination using the Bradford technique (46) and for measure-stracted from the observed spectrum of the vanadium compounds.
ment of alkaline phosphatase activity (10–20%) as has been pre-When vanadium(IV) compounds were added to the cell media (or
viously described (17). This assay has been used as a marker offormed during the experiment), EPR spectroscopy was also used to
osteoblast-phenotype expression in cell cultures (44, 47, 48).monitor these compounds.
Sample concentrations as analyzed by 51V NMR spectroscopy were Glucose consumption assay. Cells in 24-well plates were cultured
0.33–5.00 mM, by EPR spectroscopy 0.500–2.00 mM, and by uv– with different vanadium compounds in 0.5 ml serum-free DMEM.
visible spectroscopy 2.50–15.0 mM. Additional experimental details After 24 h at 377C, the conditioned medium was removed and sepa-
rated from of cells by centrifugation at 8000g/3 min. The glucose
concentration remaining in the mediumwasmeasured by the glucose
oxidase enzymatic method (Wiener Lab., Argentina), as described3 Abbreviations used: Vi, vanadate; Voxal, vanadium oxalate;
previously (45).Vcitr, vanadium citrate; Vtar, vanadium tartrate; V-NTA, vanadium
nitrilotriacetate; FBS, fetal bovine serum; DMEM, Dulbecco’s modi- Morphology. Cells were plated into 35-mm dishes at a density of
2 1 104 cells/dish. After 24 h, they were washed with DMEM andfied Eagle’s medium; ALP, alkaline phosphatase activity; PDGF,
platelet derived-growth factor; PBS, phosphate-buffered saline. incubated in fresh DMEM plus different vanadium compounds (25
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mM) for an additional 24 h. Cells were subsequently washed and
stained with crystal violet as before, and morphological changes were
examined microscopically.
Statistical methods. At least three experiments were performed
by triplicate for each experimental condition. Data are expressed as
the mean { SEM. Statistical differences were analysed using Stu-
dent’s t test or analysis of variance when suitable. Linear correlation
analysis was performed by Pearson’s correlation coefficient.
RESULTS
Stability studies in the cell media. The vanadium
chemistry under physiological conditions is complex
and poorly understood even for well-known vanadium
compounds and compounds often used in biological
studies (22, 24, 29). Attributing a certain biological re-
sponse to a particular vanadium compound is therefore
difficult and has not been appropriately considered in
studies with vanadium compounds (24). Although it is
not known which compounds are transported into the
cells, information on the stability of each compound
during cell treatment and determination of what other
compounds form during the cell incubation will provide
a valuable basis to interpret the mechanism of the ob-
served effects. Figure 1 shows the 51V NMR spectra of
a solution of 2.5 mM V-NTA in DMEM media immedi-
ately after dissolution of the compound. An identical
spectrum is observed for a concentration of stock solu-
tion of V-NTA (spectrum not shown). The spectra at 5
and 22 h clearly show hydrolysis of a significant frac-
tion of the V-NTA complex, and signals attributed to
vanadate are observed in the 51V NMR spectra (the
speciation of vanadate at neutral pH has been pre-
FIG. 1. The 51V NMR spectra of 5.0 mM V-NTA are shown immedi-viously reviewed in Ref. 29). Voxal and Vcitr also form
ately after dissolution of the compound in the cell medium (top), aftervanadate in the cell media, although hydrolysis of these
5 h, and at 22 h. The 51V NMR spectrum of a solution of DMEMcompounds is significantly faster than that illustrated
media at 377C containing 5.0 mM vanadate is shown for comparison.
for V-NTA in Fig. 1 (for some experimental data see Signals due to V-NTA and vanadate oligomers (V1, V2, V4, and V5)
Fig. 2, left). The vanadium(IV) compound Vtar showed are indicated.
50% hydrolysis after 22 h of incubation in the cell me-
dia. The hydrolyzed vanadium(IV) species then oxi-
dized to vanadate (as monitored by both 51V NMR and solution contained about 20% compound after 24 h
(data shown in Fig. 2 are for 5.0 mM compounds). TheseEPR spectroscopies; data not shown).
The cells were incubated with vanadium compounds studies allowed us to estimate the speciation of vana-
dium compounds at 25 mM even though the detailedat concentration of 25 mM. The analytical methods
available do not allow for distinction among different decomposition reactions of these compounds in the
presence of cell media are not fully understood (decom-vanadium species in solution at this concentration. It
was necessary to measure their stability at higher con- position is likely to involve both hydrolysis and redox
reactions). The projected stability curves for 25 mM ofcentrations and to estimate the existence of each vana-
dium compound in the DMEMmedia under cell growth each vanadium compound are shown in Fig. 2 (right).
From this figure it can be seen that Voxal is hydrolyzedconditions. Thus, the stability studies of vanadium
compounds were carried out in a cell-free system, in immediately and Vcitr is essentially 100% converted to
vanadate after 7 h. However, some of the V-NTA andDMEMmedia at 377C, pH 7.4. Since the relative stabil-
ity of the V-NTA and Vtar complexes are dependent on the Vtar compounds remain unchanged in solution, al-
though both of these species also form significant con-the concentration of the compound, a series of at least
six different concentrations were followed up to 24 h. centrations of vanadate. For example, after 24 h incu-
bation with 25 mM Vtar, 10 to 15 mM vanadate wasFor example, a 5.0 mM V-NTA solution contained
ú65% compound after 24 h, whereas a 0.50 mM V-NTA formed.
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TABLE I
Effect of Different Vanadium Compounds
on Cell Protein Content
Protein [mg/well]
Compounds UMR 106 cells (n Å 7) MC3T3E1 cells (n Å 8)
None (basal) 118 { 1 40 { 3
Vanadate 169 { 3** 48 { 2*
FIG. 2. Experimental data at 2.5 mM (left) and estimated stabilities Voxal 173 { 5** 47 { 2*
at 25 mM (right) of vanadium compounds in DMEM media at 377C. Vcitr 173 { 4** 52 { 2**
The information is based on experimental determination of the sta- Vtar 159 { 2** 52 { 3**
bility of each vanadium compound using a combination of 51V NMR, V-NTA 163 { 2** 42 { 6
EPR, and uv–vis spectroscopy of the respective compounds in con-
centrations ranging from 0.33 to 15.0 mM. A minimum of five differ-
Note. Cells were incubated with 25 mM vanadium compounds at
ent concentrations for each vanadium compound were followed for
377C/24 h. Protein content was evaluated as described under Experi-
up to 24 h under the conditions of cell growth. The symbols represent
mental Procedures. Results are expressed as X { SEM; differences
vanadate (h), V-NTA (j), Vtar (s), Vcitr (l), and Voxal (m).
versus basal are *P õ 0.01 and **P õ 0.001.
Since all four compounds generate vanadate upon compounds. Vanadate, Voxal, Vcitr, and V-NTA
incubation with the cell media we would expect that strongly stimulated cell proliferation in UMR106 cells
all four vanadium compounds would exhibit some of (Fig. 3A). On a molar basis, Vtar was less effective than
the biological responses of vanadate, albeit at different vanadate (115 { 3 vs 133 { 8, respectively; P õ 0.05),
levels. Both V-NTA and Vtar remain intact for longer but still induced cell growth. On the other hand, in
periods of time and thus have the potential to exhibit MC3T3E1 cells (Fig. 3B), vanadate, Voxal, Vcitr, and
a response which could be differentiated from that of Vtar increased cell proliferation to the same extent,
vanadate. while V-NTA did not affect the proliferation of this cell
line as tested in three independent experiments.Effect of vanadium compounds on cell growth. Fig-
ure 3 shows the proliferation assay, as measured by The effect of vanadium derivatives on total cell pro-
tein was also assessed (Table I). At 25 mM, all vanadiumthe crystal violet bioassay, after 24 h of exposure of
osteoblast-like cells to 25 mM of a series of vanadium derivatives significantly increased total protein content
FIG. 3. Effect of different vanadium compounds on cell proliferation. UMR106 (A) and MC3T3E1 (B) were incubated with 25 mM of Vi
(vanadate), Voxal, Vcitr, Vtar, or V-NTA, at 377C/24 h. Results are expressed as % basal, X { SEM, n Å 8, MC3T3E1 and n Å 11, UMR106.
Basal values are 9.5 1 104 cell/ml (UMR106) and 2.2 1 104 cell/ml (MC3T3E1). Differences vs basal are #P õ 0.02, *P õ 0.01, and **P õ
0.001.
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TABLE II evident after 12 h of incubation. Control cultures
showed polyhedral cells with slender lamellar expan-Effect of Vanadium Compounds on Glucose Consumption
sions (Fig. 5A). These expansions appeared to join to
each other among neighboring cells. The nuclei showedGlucose consumed [mg/dl]
moderately thick chromatin granules. The perinuclear
Compounds UMR 106 cells (n Å 9) MC3T3E1 cells (n Å 12) cytoplasm had numerous organelles and vacuoles,
while the exoplasm was diffuse and homogeneous.
None (basal) 87 { 7 39 { 4
Cells incubated with vanadate, Voxal, and Vcitr be-Vanadate 185 { 7** 63 { 6*
came spindle-like and condensed. When Vtar wasVoxal 176 { 8** 55 { 3*
Vcitr 186 { 9** 60 { 3** tested on MC3T3E1 cells, slight morphological trans-
Vtar 179 { 13* 56 { 4* formations were observed after 24 h incubation. A de-
V-NTA 218 { 12**,# 55 { 4* tailed microscopic observation of the cell preparation
showed a heterogeneous cellular population, with aNote. Cells were incubated with 25 mM vanadium compounds at
main proportion of normal cells and small number of377C/24 h. Glucose consumption was evaluated as described under
Experimental Procedures. Results are expressed as X { SEM; differ- condensed and retractile cells (data not shown). V-NTA
ences versus basal are *P õ 0.01, **P õ 0.001; difference vs vana- was the strongest morphological transformer in
date, #P õ 0.05. MC3T3E1 cells. In cultures treated with this peroxo-
compound, cells were long and fusiform in shape, with
very dense cytoplasm and well-defined borders, andin UMR106 osteoblast-like cells. The effect of vana-
without connections between cells (Fig. 5B).dium compounds on cell protein was also tested on the
MC3T3E1 line. Vanadate, Voxal, Vcitr, and Vtar sig-
DISCUSSIONnificantly enhanced protein content with a pattern sim-
ilar to that of the crystal violet experiments. Thus, it Insulin, like other growth factors, regulates cell
is possible that the changes in protein content may be proliferation, differentiation, and acute metabolic
a reflection of the changes in cell proliferation. V-NTA processes in a variety of cells (4–7, 17). Vanadate
did not alter the cellular protein levels in MC3T3E1 induces insulin-like effects in animals and also in
cells, although a considerable variability between dif- cultures of bone-related cells (4–6, 17). The insulin-
ferent assays was observed. This finding was in agree- like effect has been demonstrated in primary cultures
ment with the lack of stimulation of V-NTA on such as rat calvaria cells or rabbit condrocytes as
MC3T3E1 cell proliferation. well as in cloned cell lines by enhanced synthesis of
Effect of vanadium compounds on glucose consump-
tion. All tested vanadium derivatives significantly in-
creased glucose consumption in both MC3T3E1 and
UMR106 osteoblast-like cells over basal values after a
24-h incubation (Table II). The effects were similar for
all vanadium derivatives tested at 25 mM concentration,
with the exception of V-NTA, which was more potent
than vanadate on the UMR106 line.
Vanadium derivatives inhibit cell differentiation.
The osteoblast-like phenotype was assessed by the spe-
cific activity of alkaline phosphatase. In UMR106 cells,
vanadate, Voxal, Vcitr, and V-NTA statistically inhib-
ited cell differentiation, whereas the vanadium(IV) de-
rivative Vtar showed no effect (Fig.4).
In these experiments the MC3T3E1 cells were cul-
tured for relatively short periods (3 days) and the ALP
activity was very low, since these cells had not yet
reached their typical osteoblast phenotype (44). Thus,
this parameter could not be evaluated in this cell line.
Morphology. During the course of the incubation
with vanadium compounds, it was observed that in con-
FIG. 4. Effect of vanadium compounds on UMR106 alkaline phos-trast to the osteosarcoma UMR106 cells, the MC3T3E1
phatase specific activity. Cells were incubated with 25 mM of Vi (vana-osteoblasts suffered morphological changes. In the date), Voxal, Vcitr, Vtar, or V-NTA, at 377C/24 h. Results are ex-
MC3T3E1 cells exposed to 25 mM vanadium com- pressed as % basal, X { SEM, n Å 9. Basal value is 340 { 38 nmol/
min/mg protein. Differences vs basal are *Põ 0.01, and **Põ 0.002.pounds, the extent of the morphological changes was
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FIG. 5. MC3T3E1 incubated in DMEM (control) (A). Effect of V-NTA 25 mM for 24 h (B). After this period, cells were stained with crystal
violet. Obj, 140.
DNA and of collagen and other extracellular matrix ited by another osteoblast-like cell line, the
MC3T3E1 cells. The latter is a murine calvaria-de-proteins. In addition to vanadate, we have recently
reported that VOSO4 and pervanadate also stimu- rived osteoblast-like cell line and shares many fea-
tures with osteoblasts (50). It is responsive to insulinlated cell proliferation in UMR106 osteosarcoma cells
(17). Cell lines (osteosarcoma vs normal osteoblasts) as well as to other growth factors (PDGF, IGF-I, es-
trogen) (49) and has been previously used as a modelsynthesize and secrete different amounts of growth
factors (49) and are likely to respond differently to to study osteoblast differentiation and mineraliza-
tion (47).exogenous agents. In the present report we focus our
attention on demonstrating that the effects of vana- The effect of high cell density on the responsiveness
to exogenously added compounds is not limited to thedate and other vanadium compounds are not limited
to the UMR106 osteosarcoma cells but are also exhib- MC3T3E1 cells but has also been previously reported
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for other cell types (51). It is possible that under high- and glucose consumption) and partially like VOSO4
(without affecting ALP activity and cell morphology).density conditions, considerable amounts of growth fac-
tors (like IGF-I) may down-regulate their specific recep- These observations are consistent with the partial hy-
drolysis observed for these compounds in the cell me-tors, rendering the cells unresponsive to exogenous mi-
togens. However, using conditions similar to ours, Da- dium (Fig. 2).
V-NTA, the only peroxo-compound examined in thisvidai et al. (7) found that vanadate increased thymidine
incorporation into DNA and synergized the PDGF work, is particularly interesting because of its stability
and observed biological effects. About 20% of the com-growth-promoting effect. Our results are in agreement
with their findings and furthermore demonstrate an plex remains after 15 h incubation in DMEM medium.
The fact that the cellular response to V-NTA deviateseffect by other vanadium compounds. The response of
cell line UMR106 to vanadate was similar to that of from that of vanadate suggests that V-NTA acts in a
significantly different way than vanadate (albeit con-MC3T3E1: vanadate increased cell proliferation (as
measured by crystal violet assay), protein content, and sidering that some V-NTA does generate vanadate
upon incubation with the cell media). This compoundglucose consumption (Fig 3; Tables I and II).
Vanadate, Voxal, and Vcitr increased cell prolifera- affected UMR106 cell proliferation and differentiation
to a magnitude indistinguishable from that of vanadatetion, protein content, and glucose consumption to the
same extent in UMR106 and MC3T3E1 cells (Fig.3; (Figs. 3A and 4; Table I). However, it was statistically
significantly more potent than vanadate in increasingTables I and II). These three compounds also inhibited
the ALP-specific activity in the former cell line (Fig. glucose consumption in UMR106 cells (Põ 0.05) (Table
II). On the other hand, V-NTA did not affect mitogen-4). These results were also reproduced in a series of
experiments performed in the presence of 25 mM EDTA esis (Fig. 3B) or cell protein content (Table I) in
MC3T3E1 cells under our working conditions. Theseand thus suggest that the effect of vanadium com-
pounds on cell differentiation, as assessed by ALP ac- observations would be consistent with the possibility
of V-NTA not being taken up and/or metabolized by thetivity, is not a direct in vitro inhibitory effect of vana-
dium compounds but probably a change in the enzyme MC3T3E1 osteoblast-like cells but inconsistent with
the observed enhanced glucose consumption (Table II).content as we have previously suggested (17).
The observed biological responses of Voxal and Vcitr This could suggest that this compound exerts selective
effects on MC3T3E1 cells. Furthermore, the morpho-are consistent with the hydrolysis of each vanadium
derivative to vanadate and free ligand. Indeed, Voxal logical studies showed that V-NTA was the strongest
morphological transformer in MC3T3E1 cells (Fig. 5).is rapidly hydrolyzed in the culture media as shown by
51V NMR (Fig. 2) and suggested by previous studies Transformation suggests that this compoundmay have
cytotoxic effects on the normal osteoblast MC3T3E1with these compounds (24). Even though Vcitr is sig-
nificantly more stable, it partially hydrolyzed under cell lines, as has been previously suggested for other
peroxovanadium derivatives (59). The experimental ev-our incubation conditions (Fig. 2), and the effects of
this compound cannot be distinguished from the effect idence presented here is consistent with the possibility
that tumorigenic and normal osteoblast-like cells couldof vanadate (Figs. 3 and 4; Tables I and II).
Vtar is a relatively stable vanadium(IV) compound respond differently to some vanadium compounds, as
in the case of V-NTA.in DMEM medium. After 15 h of incubation at 377C,
about 10 to 20 mM vanadate was generated from 25 mM In conclusion, Voxal and Vcitr induce insulin-like ef-
fects on osteoblast-like cells similar to those of vana-Vtar. Under our experimental conditions, Vtar did not
affect UMR106 differentiation (Fig. 4) but stimulated date. These effects are consistent with their rapid hy-
drolysis to vanadate. In contrast, relatively stable com-cell proliferation, protein content, and glucose con-
sumption (Fig. 3; Tables I and II) in either UMR106 or pounds such as Vtar and V-NTA exhibit certain
responses, some of which are not observed with vana-MC3T3E1 osteoblasts. The lack of effect of this com-
pound on ALP-specific activity of UMR106 cells (Fig. date. These studies clearly demonstrate that modified
vanadium compounds given sufficient stability will4), a marker of osteoblast differentiation, is consistent
with our previous results with VOSO4 (17). On the show some selectivity in their biological action.
other hand, this vanadium(IV) compound slightly af-
fected cell morphology, in contrast to the tested vanadi-
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